Dr. Guo Liang Yu is a co-founder, Executive Director, Chairman and Chief Executive Officer of Apollomics. Dr. Yu has been one of the key management members of the Company and has been actively involved in its business, strategy and operational management since its establishment. He has over 31 years of experience in the pharmaceutical industry and academic research. He is a serial entrepreneur and has co-founded over ten startup companies in biotech and the healthcare sectors, including Immune-Onc Therapeutics, Inc. in Palo Alto, United States. During his co-founding of our Group, Dr. Yu was the executive chairman of Crown Bioscience International and he was also a venture partner with OrbiMed Asia Limited.
Dr. Yu obtained his Ph.D. degree in molecular biology from the University of California, Berkeley in the U.S. He has served important roles in numerous social organizations, including the founding president of the Chinese Biopharmaceutical Association USA. Inc. and as a board member of Ray Wu Memorial Fund. Dr. Yu is currently a member of the Board of Directors of the following companies: Immune-Onc Therapeutics, Inc., Zhejiang Innoforce Pharmaceuticals Co., and Inmagene Biopharmaceuticals.